Navigation Links
STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results
Date:10/30/2008

nt, equipment and intangibles. STERIS's calculation of free cash flow may vary from other companies.

This news release, and the conference call referenced here, may contain statements concerning certain trends, expectations, forecasts, estimates, or other forward-looking information affecting or relating to the Company or its industry that are intended to qualify for the protections afforded "forward-looking statements" under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date of this report, and may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "targets," "forecasts," "potential," "confidence," and "seeks," or the negative of such terms or other variations on such terms or comparable terminology. Many important factors could cause actual results to differ materially from those in the forward-looking statements including, without limitation, disruption of production or supplies, changes in market conditions, political events, pending or future claims or litigation, competitive factors, technology advances, actions of regulatory agencies, and changes in government regulations or the application or interpretation thereof. Other risk factors are described in the Company's Form 10-K and other securities filings. Many of these important factors are outside STERIS's control. No assurances can be provided as to any outcome from litigation, regulatory action, administrative proceedings, government investigations, warning letters, cost reductions, business strategies, level of share repurchases, earnings and revenue trends, expense reduction or other future financial results. Unless legally required, the Company does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized. Other poten
'/>"/>

SOURCE STERIS Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against Superbugs
2. MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008
3. Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital
4. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
5. Environmental Tectonics Corporations BioMedical Systems Division Places Two Monoplace Chambers at East Orange (NJ) General Hospital
6. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
7. Techne Corporation Declares Dividend
8. LI-COR Biosciences and Euthanex Corporation Provide Anesthesia System for Small Animal Imaging
9. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
10. Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
11. Baxa Corporation Features PadLock(R) Set Saver at the ANCC National Magnet Conference(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 /PRNewswire/ - JSS Medical Research Inc., a Montreal ... concluded the acquisition of Max Neeman International (MNI), with head office ... are located in Ahmedabad, Bangalore , ... US subsidiary, a regional office is located North Carolina, ... by the recent equity investment transaction into JSS with Capital Croissance ...
(Date:5/4/2015)... Israel , May 4, 2015  Tikcro Technologies ... its annual report on Form 20-F for the fiscal ... and Exchange Commission ("SEC"). The annual report on Form ... development of antibodies in the area of cancer immune ... superior qualities of high specificity and binding in targeting ...
(Date:5/4/2015)... TORONTO , May 4, 2015 /PRNewswire/ - ... its partners are pleased to announce the formation ... focussed on developing treatments for cancer that harness ... company represents a unique collaboration between the Children,s ... (CHEO) Research Institute, McMaster University, the Ontario Institute ...
(Date:5/4/2015)... Achieved primarily through a proprietary paraffin and stain ... 100x better detail than the industry standard. But ... microscopy methods, it needed another medium to measure its ... of reference because it represents the highest standard of ... earliest discovery days of Ultralight Histology was to reverse ...
Breaking Biology Technology:JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4Tikcro Technologies Files Annual Report on Form 20-F for the Year Ended December 31, 2014 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3
... any tissue with the Big Blue transgenic,rodent ... Barry W. Glickman ,Centre for Environmental Health, University of ... transgenic rodent mutation,assay,* which carries the ... vector, it is easy to study mutations in male,and ...
... and efficient PCR cloning with pcmv-script PCR cloning kit ... Tim Sanchez Quinn,Lu ,Stratagene Cloning Systems, Inc. , ... cloning,strategy by introducing a new vector for ... The pcmv-script PCR,cloning kit ...
... reagent is effective with a wide variety ... ,Genetic Applications LLC , LipoTAXI ... delivery of foreign DNA into mammalian,cells. In this study, ... conditions for transfecting a reporter plasmid in three common ...
Cached Biology Technology:Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 2Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 3Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 4Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 5Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 6Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer 7Mammalian Expression Vector for Efficient Cloning of PCR Fragments 2Mammalian Expression Vector for Efficient Cloning of PCR Fragments 3Mammalian Expression Vector for Efficient Cloning of PCR Fragments 4A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7,Cell Lines 2A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7,Cell Lines 3
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) ... Recognition Market 2015-2019" report to their offering. ... to grow at a CAGR of 23.5 percent over ... present scenario and the growth prospects of the Global ... the market size, the report considers the revenue generated ...
(Date:3/24/2015)... BEACH GARDENS, Fla. , March 24, 2015 ... biometric identity management solutions, today announced that its ... premium clothing accessory retailer Goorin Bros . ... The Crossmatch biometrics-based solution secures access to the ... from the increased risk of data breaches. ...
(Date:3/23/2015)... ANGELES , March 23, 2015  In the ... Federal fraud case conviction losses. This figure accounts for ... which, according to The Nilson Report, exceeds $11 billion ... investigative tool after a crime has occurred. Investor ... and polygraph expert Joe Paolella partnered to ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... French . Toronto (June 5, 2009) ... to announce another measure to address the H1N1 flu virus. ... network focused on pandemic vaccine evaluation. The network will strengthen ... pandemic influenza vaccine and vaccination programs. The network was ...
... may shape the human genome much more slowly than ... within and among continents, the expansions and contractions of ... heavily influenced the distribution of genetic variations in populations ... from the Howard Hughes Medical Institute, the University of ...
... EAST LANSING, Mich. A pair of Michigan ... $400,000 for their cardiovascular research projects as part of ... The money, from the National Institutes of Health ... to preserve and create jobs in Michigan while also ...
Cached Biology News:Government of Canada announces funding for research on the H1N1 flu virus 2Geography and history shape genetic differences in humans 2MSU researchers receive $400,000 in first wave of stimulus funding 2
Porcine Serum US Origin 6 Months or Older...
SEQUENASE PCR PRODUCT PRE-SEQU, 1 EA. Category: SEQUENASE....
... off the clot from fasted Cynomolgus monkeys of mixed ... Anticoagulants: N-02: Citrate N-04: ... Potassium Oxalate N-10: EDTA (Na) N-03: ... CPD N-09: K3EDTA N-11: Heparin ...
adult...
Biology Products: